The hypolipidemic effect of Portulaca oleracea L. stem on hyperlipidemic Wister Albino rats  by El-Newary, Samah Ali
Annals of Agricultural Science (2016) 61(1), 111–124HO ST E D  BY
Faculty of Agriculture, Ain Shams University
Annals of Agricultural Science
www.elsevier.com/locate/aoasThe hypolipidemic eﬀect of Portulaca oleracea
L. stem on hyperlipidemic Wister Albino rats* Tel.: +20 1000464073, +20 2 33371362; fax: +20 2 33370931.
E-mail address: samahelnewary@yahoo.com.
Peer review under responsibility of Faculty of Agriculture, Ain-Shams
University.
http://dx.doi.org/10.1016/j.aoas.2016.01.002
0570-1783  2016 Production and hosting by Elsevier B.V. on behalf of Faculty of Agriculture, Ain Shams University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Samah Ali El-Newary *Medicinal and Aromatic Plants Research Department, National Research Center, Dokki, Postal code 12311, Giza, EgyptReceived 19 November 2015; accepted 14 January 2016
Available online 12 February 2016KEYWORDS
Portulaca oleracea;
Stems;
Lipids;
Polyphenolics;
Flavonoids;
Saponins;
Tannins;
MucilageAbstract Portulaca oleracea has been listed in the World Health Organization as one of the most
usedmedicinal plants. Portulaca oleracea stems (POS) acts about 75% fromweight of plant. The pro-
duction of stems was the most economic between other organs. This study carried out to investigate
the hypolipidemic effect of POS preparations. Three preparations of POS were tested: stem powder
(POS-powder), stem infusion (POS-infusion) and stem 70% ethanolic extract (POS-ethanolic 70%). POS
preparations contained useful components with different proportion such as polyphenolics,
flavonoids, alkaloids, tannins, saponins and mucilage. The effect of POS on weight and lipid profile
investigated on dietary hyperlipidemic Wister Albino rats fed on hyperlipidemic diet contained
20% fat, 1% cholesterol and 0.25%colic acid. The experimental periodwas 8-weeks. POS-powder form
was supplemented at 10% in hyperlipidemic diet while POS-infusion and POS-ethanolic 70% force fed by
1.0 g/kg body weight. The hyperlipidemic model described with elevated weight, feed intake, total
cholesterol (TC), total lipids (TL), triglycerides (TG), low density lipoprotein cholesterol (LDL-C),
very low density lipoprotein cholesterol (VLDL-C) levels and risk ratio was significantly, compared
with untreated control after 4 and 8 weeks. Contrary high density lipoprotein cholesterol (HDL-C)
of hyperlipidemic control was decreased significantly. POS preparations improved all obvious abnor-
mal lipid parameters and risk ratio compared with hyperlipidemic control. The abnormalities, which
was shown on liver status of hyperlipidemic rats were ameliorated by administration of POS prepa-
rations significantly. Liver histology showed significant improvement after treating hyperlipidemic
rats by POS form compared with hyperlipidemic control.
 2016 Production and hosting by Elsevier B.V. on behalf of Faculty of Agriculture, Ain Shams
University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Portulaca oleracea L. (subsp. oleracea) is a weed spread in the
Egyptian fields has been used as a nutritious vegetable for
human nutrition. P. oleracea has been mentioned in Egyptian
texts from the time of the Pharaohs (Kesden and Will, 1987). It
has been listed in the World Health Organization as one of the
most used medicinal plants. The taste of plant is like spinach:
112 S.A. El-Newarya slightly acidic and salty taste (Samy et al., 2004). In folk med-
icine, it has been used for remediation dysentery, boils and
sores, eczema, erysipelas, checking cough, dispelling phlegm
and snake and insect-bite, diuretic, febrifuge, antiseptic,
antispasmodic and vermifuge (Xaing et al., 2007). Also, many
pharmacological effects of P. oleracea were documented like
anti-oxidation, anti-bacteria, anti-virus, anti-ulcerogenic,
anti-inflammatory, skeletal muscle-relaxant, wound-healing
and hypoxic nerve tissue protective effect (Parry et al., 1993;
Rashed et al., 2003; Xie, 2002; Wang et al., 2007). The seeds
or its extracts; infusion, 70% alcoholic and petroleum ether
have hypolipidemic and hypoglycemic activity in hyperlipi-
demic rats (El-Newary et al., 2011).
P. oleracea is a good source of compounds with a good
human health benefits. These compounds include omega-3
fatty acids and b-carotene, vitamins and essential amino acids
and glutathione (Liu et al., 2000; Simopoulos et al., 1992). It
contains phenolics and alkaloids (Spina et al., 2008; Xaing
et al., 2007). Flavonoids of P. oleracea L., contain Kaemp-
ferol, apigenin, myricetin, quercetin and luteolin as a major
components (Xuqin et al., 2005).
The stem of P. oleracea (POS) acts about 75% from the
weight of plant. It means that, stem was the biggest organs
of plant and production of POS was economic. The produc-
tion of stems was reached 22–25 and 2–2.7 ton/Fadden fresh
and dry weight respectively. POS was very mucilaginous (El-
Newary, 2012). Total fatty acid contents in POS ranged from
0.5 to 0.9 mg/g and a-linolenic is the major fatty acid followed
by linoleic acid and palmitic acid Liu et al. (2000). However,
the studies on the chemical and biological evaluation of POS
stems were very little.
Hyperlipidemia is a heterogeneous disorder described by an
elevation on total cholesterol (TC), triglycerides (TG), very
low density lipoprotein cholesterol (VLDL-C), low-density
lipoprotein cholesterol (LDL-C), free fatty acids (FFA),
and apolipoprotein B (apo B) levels, as well as reduced
high-density lipoprotein cholesterol (HDL-C) levels. These
disorders were happened as results of metabolic disorders, or
dietary and lifestyle habits (Kolovou et al., 2005). Several stud-
ies reveal that an increase in HDL-C and decrease in TC,
LDL-C and TG are associated with a decrease in the risk of
ischemic heart diseases. Many drugs have been reported as a
hypolipidemic, including bile acid, resins, statins, fibrates, niacin
and cholesterol absorption inhibitors are common treatments
for hyperlipidemia. However, severe side effects are associated
with the use of these drug for lipid-lowering medications
(Rodenburg et al., 2004). Most of the antihyperlipidemic drugs
are causing significant reduction in both TC and HDL-C
(Saravanakumar et al., 2010). Many natural compounds were
documented as a hypolipidemic agents such as polyphenolics,
flavonoids, tannins, alkaloids, phytosterol, unsaturated fatty
acids and dietary fibers. Many functional foods, including flax-
seed, garlic, viscous fiber, almonds, nuts and soy proteins have
been examined as hypolipidemic agents (Micallef and Garga,
2009). These functional foods are effective in reducing both
TC, TG and LDL-C; and have no effect on HDL-C levels.
Many medicinal plants were documented as a hypolipidemic
agents: decreased TC, TG, LDL-C and increased HDL-C.
These plants are Lycium barbarum polysaccharides (Ming
et al., 2009), Flaxseed lignin (Fukumitsu et al., 2008 and
Fukumitsu et al., 2010), Sesbania grandiflora
(Saravanakumar et al., 2010), Adonis vernalis, (Lateef et al.,2012), purslane (P. oleracea L.) seeds (El-Newary, 2012) saf-
fron (Mashmoul et al., 2013) and Cordia dichotoma pulp
(Sulieman and El-Newary, 2014).
The main target of this study was to evaluate the ant-
hyperlipidemic and hepatoprotective effect of POS preparations
against hyperlipidemic diet induced-hyperlipidemic rats. The
protection effect of POS preparations was estimated by surveil-
lance lipid profile (TL, TC, TG, LDL-C, VLDL-C andHDL-C)
and liver functions (total protein, albumin, globulin, alanine
aminotransferase and aspartate aminotransferase).
Material and methods
Plant material
Collection of plants
Cultivated P. oleracea subsp. oleracea (Riglah) was collected
during summer 2014 from El-Sharkia Governorate, Egypt.
Plants were identified by Dr. A. El-Megaly (Department of
the herbarium of Flora and Phytotaxonomy Research, Horti-
culture Research Institute, Agriculture Research Center). The
voucher specimen (No. 136) was deposited in the herbarium of
(CAIM). Stems of plant were separated and air-dried at room
temperature and completed drying on oven at 50 C for 24 h.
Preparation of POS-infusion
Grinded dried POS (100 g) was steeped in liter boiling water
and left over night at room temperature. Next, this infusion
was decanted and centrifuged. The supernatant was dried by
rotary evaporator and completed dryness on oven at 50 C.
The yield was 22.50 g/100 g dry stem (Afifi et al., 2005).
Preparation of POS-ethanolic 70%
POS powder (1000 g) was exhaustively extracted by cold mac-
eration process with petroleum ether 40:60, chloroform, ethyl
acetate and ethanol 70% sequentially according to Devi and
Sharma (2004). The yield of ethanol 70% was 156.32 g/kg.Chemical composition of POS preparations
 Crude fat% of Portulaca oleracea stems was determined
according to the methods described by A.O.A.C. (2000).
 Unsaponifable and saponifable matter of Portulaca oler-
acea oil were separated and identified according to method
of A.O.A.C. by GLC.
 The non-saponifable matter was prepared according to A.
O.A.C standard method No. 933/08.
 Fatty acid methyl esters of Portulaca oleracea stems oil were
determined according to A.O.A.C standard method No.
969/33 (Firestone, 1990).
Phytochemical screening of POS preparations; POS-10% powder,
POS-infusion and POS-ethanolic 70% were performed using
standard procedures, which was described by Balbaa et al.
(1981). Total polyphenols were determined spectrophotometri-
cally by Folin-Denis reagent as gallic acid according to
Gorinstein et al. (2004). The total flavonoids and condensed
tannins content were determined spectrophotometrically
according to method of Lin and Tang (2007) and Julkunen-
Titto (1985). Total saponins, total alkaloids and mucilage
Different preparations of Portulaca oleracea L. stem 113contents were determined gravimetrically according to the
methods of Edeoga et al. (2005), Onwuka (2006) and khuller
et al. (1998).
Biological studies of POS preparations
Acute toxicity assay
The acute toxicity test for POS-infusion and POS-ethanolic 70%
was carried adopting the method of Bruce (1985). Swiss albino
mice (n= 8) was subjected to a 24 h. The dosing patron was 1,
2, 3, 4, 5, 6, 7, 8, 9 and 10 g/kg body weight by orally while the
control group received only the normal saline. All groups were
observed for any gross effect or mortality during 24 h. Alive
animals after 24 h, were kept for another 14 days and observed
daily for behavioral and body weight change.
Hypolipidemic activity of POS preparations
(a) Animals: This study followed and respected the ethical
guidelines of Medicinal Research Ethics Committee,
National research Center, Egypt. Healthy male albino
rats Wistar strain (30 rats) each weighing 120–140 were
used for study. The rats were obtained from central ani-
mal house of National Research Centre, Dokki, Giza,
Egypt. Animals were housed in polypropylene cages
under laboratory conditions (20–25 C, 50–60% humid-
ity, 10–12 h light/dark cycle) at the animal facility of ani-
mal house of National Research Centre, Dokki, Giza,
Egypt. Water was available ad libitum and food was free
over 8-week period.
(b) Diets: Two types of the diet were prepared. The first type
was standard one which was obtained from animal
house of National Research Centre, Dokki, Giza, Egypt.
The second one was hyperlipidemic diet, which was
obvious standard diet supplemented with 20% camel
fat, 1% cholesterol and 0.25% bile’s acids (Ausman
et al., 2005).
(c) Dosing: One dose of POS-infusion and POS-ethanolic 70%
was tested as the results of LD50, 1.00 g/kg (1/10 of
LD50) body weight. After adaptation period (7 days)
animals were divided into five groups (each 6 rats).
The first group fed on standard diet and force fed by
normal saline solution to keep as untreated control.
The second one fed on hyperlipidemic diet and force
fed by normal saline solution to keep as hyperlipidemic
control. The third one fed on hyperlipidemic diet supple-
mented with 10% POS-powder as HFD-POS-powder 10%
group. The fourth and fifth groups fed on hyperlipidemic
diet and force fed by POS-infusion or POS-ethanolic 70% at
dose 1.00 g/kg/body weight/day as HFD-POS-infusion
and HFD-POS-ethanolic 70% groups respectively. The
rats were weighted every week, and food weighted daily
even the end of experiment.
(d) Samples: Blood samples were obtained from each of the
eye venous plexuses by capillary tube at zero time (zero-
day) and after 4-weeks. At the end of the experimental
period (8-weeks) fasting rats, were sacrificed by ether
and blood and organs were collected. Blood was cen-
trifuged (4000g, 10 min, 4 C by using Sigma labor cen-
trifugen), and serum was separated. Livers were
weighted freshly and kept in formalin 10% for patholog-ical studies. Pathology examination of collected livers
was carried out by the methods of Bancroft and
Gamble (2001).
Biochemical analysis of samples
All parameters were determined in serum spectrophotometri-
cally using kits obtained from ElITECH (ELITech Group
12–12 bis rue Jean Jaure`s 92800 Puteaux France). Serum
glucose was determined freshly according to Trinder (1969).
TC, HDL-C, TG and TL were determined according to meth-
ods of Allain et al. (1974), Naito and Kaplan (1984), Fossati
and Prencipe (1982) and Estadella et al. (2004) respectively.
LDL-C, VLDL-C and risk ratio were calculated according to
Friedewald et al. (1972), Naito and Kaplan (1984) and
Kikuchi et al. (1998) respectively.
Liver functions: total protein, albumin and aspartate
aminotransferase (AST), and alanine aminotransferase
(ALT) activities were determined according to the methods
of Henry (1964), Doumas et al. (1971) and Reitman and
Frankel (1957) respectively.
Renal functions: urea and uric were estimated according to
the methods of Tabacco et al. (1979) and Gochman and
Schmitz (1971) respectively.
Statistical analysis
All values are expressed as the mean ± standard error of the
mean. Data were analyzed using a linear regression or a two
ways analysis of variance (ANOVA) using dancnn test
(COSTAT-C program, 1988) tests of significance where appro-
priate. A value of p< 0.05 was the criterion of significance.
Results
Chemical composition of POS preparations
Composition of POS-powder crude lipids
POS-powder contains 2.25% crude lipids. Lipids of POS-powder
contain 50.00% unsaponifable matter and 31.38% saponifable
matter. Unsaponifable matter consisted of hydrocarbons and
sterols (Fig. 1). Hydrocarbons ranged between C5 the minor
component, pentane (0.001%) and C20 the major components,
eicosane (8.60). Sterols ranged between beta-sitosterol major
components, 10.90% and campasterol, 1.55% the minor
component.
The fatty acids (saponifable matter) composition of stems
consists of saturated and unsaturated fatty acids: 46.29%
and 38.64% respectively (Fig. 2). Palmatic acid (C16:0) was
the major saturated fatty acid, which acts 24.68%, while the
minor one was meristic acid (0.55%). Unsaturated fatty acid
was composed of a-linolenic acid; C18:3 (15.20%), tetra-
cosanoic acid C24:4 (10.21%), arachidonic C20:4 (7.07%)
and ɤ-linolenic acid; C18:3 (6.16%).
Phytochemicals components of POS preparations
The phytochemical screening of POS preparations showed that
POS-powder, POS-infusion and POS-ethanolic 70% contain carbohy-
drates, tannins, flavonoids, alkaloids and saponins. Stems
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Fig. 1 Unsaponifable matter of Portulaca oleracea stems crude lipids.
2.01
2.09
3.64
0.55
24.68
15.2
6.16
7.07
13.32
10.21
46.29
38.64
0 5 101520253035404550
Caprolic acid (C8:0)
Capric acid (C10:0)
Lauric acid (C12:0)
Myristic acid (C14:0)
Palmatic acid (C16:0)
α-linolenic acid (C18:3)
ɤ-linolenic acid (C18:3)
Arachidonic acid (C20:4)
Tetraecosanic acid (C24:0)
Tetracosanoic acid (C24:1)
Saturated fatty acids
Unsaturated fatty acids 
% 
fa
tty
 a
ci
ds
 
Fig. 2 Fatty acids of Portulaca oleracea stems crude lipids.
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Fig. 3 Phytochemical composition of Portulaca oleracea stems preparations.
114 S.A. El-Newarypowder only contained sterol and/or terpenoids. POS-powder,
POS-infusion contains mucilage. POS-powder, POS-infusion and
POS-ethanolic 70% did not contain neither anthraquinones nor
volatile oils. POS-powder contains crude fiber about 24.11
± 1.05% (as insoluble dietary fiber).Data in Fig.3 reported that, POS preparations contained
polyphenolics and flavonoids, the high amount concentrated
in POS-ethanolic 70%: 6.69% and 1.16%. Total alkaloids were
present in all preparations of stems, while POS-infusion contains
highest amount: 11.68%, compared with other preparations.
Different preparations of Portulaca oleracea L. stem 115POS-powder contains high amount of mucilage about 21.42%,
while POS-ethanolic 70% did not contain mucilage. Condensed
tannins was present in POS preparations and POS-infusion con-
tains the highest content: 0.27%. Total saponins content
occurred in POS preparations and the highest content showed
in POS-ethanolic 70%; 2.15%.
The hypolipidemic activity of POS preparations
Potential acute toxicity of POS preparations
Acute toxicity of POS-infusion and POS-ethanolic 70% was studied
on mice after their orally administration, for 24 h. POS-infusion
or POS-alcoholic 70% did record any mortality or any apparent
symptoms toxicity during the first 24 h or after following
14 days under observation. The obtained results revealed that
POS-infusion and POS-ethanolic 70% were safe up to 10 g/kg.
Effect of POS on serum glucose
At zero time, there is no significant difference found among
glucose of all groups. Feeding on hyperlipidemic diet elevated
glucose level of hyperlipidemic control after 4-weeks (68.56%)
(71.57%) and 8-weeks (68.56%), compared with untreated
control.
Administration POS preparations for 4 and 8-weeks ame-
liorated glucose levels, compared with hyperlipidemic control
(PP 0.05). HFD-POS-powder 10% caused the highest ameliora-
tion on glucose level (49.63%) after 4-weeks followed by HFD-
POS-ethanolic 70% after 8-weeks (42.20%), compared with each
hyperlipidemic control. HFD-POS-stems 10% restored glucose
level lower than that of untreated control as well as values at
zero time.
Treatments factor improved glucose levels significantly,
compared with hyperlipidemic control. HFD-POS-stems 10%
recorded the highest influence on glucose. Time factor
increased glucose levels significantly after 4-weeks and 8-
weeks with respect of zero time (see Table 1).
Effect of POS preparations on lipid profile
At the zero time lipid profile of all groups was nearly equal,
while feeding on hyperlipidemic diet for 4 and 8 weeks caused
significant elevation on TL (87.19% and 85.35%), TG andTable 1 Effect of Portulaca oleracea stems preparation on serum G
Treatments Time of administration (weeks)
Zero-day 4-w
Untreated control 63.0gh ± 1.0 65
Hyperlipidemic control 63.7fgh ± 1.4 11
HFD-POS-powder 10% 61.9
gh ± 2.2 56
HFD-POS-Infusion 60.7
h ± 0.5 75
HFD-POS-ethanolic 70% 61.2
h ± 3.3 94
Time mean 62.1B 80
Treatments Tim
LSD 2.7 2.1
Data in table were analyzed by two ways.
P 6 0.05, value with the same letter has no significant but value with difVLDL-C (154.31% and 166.67%), TC (120.04% and
126.46%) and LDL-C (489.95% and 497.06%) of hyperlipi-
demic control rats with respect of each untreated control after
4 and 8 weeks respectively. In contrary administration of
hyperlipidemic diet reduced HDL-C significantly after 4-
weeks (31.62%) and after 8-weeks (36.18%) of hyperlipidemic
control rats compared with each untreated control. Therefore
risk ratio of rats was significantly magnified by about ten times
in comparison with untreated control.
The POS treatments influence as shown in Tables 2 and 3
caused significant normalization on lipid profile compared
with hyperlipidemic control. POS-infusion was the most effective
treatment on lipid profile of rats.
The time effect was appeared on lipid profile as significant
increase on TL, TG and VLDL-C, and TC and LDL-C were
associated with increasing the time period with respect to those
values at zero time. TC, LDL-C and risk ratio were elevated
remarkably after 4-weeks and then decreased after 8-weeks
in comparison with those of zero time. TL, TG and VLDL-
C were increased after 4-weeks and were continued to increase
until 8-weeks. On the other hand HDL-C was decreased after
4-weeks and then was elevated again after 8-weeks, compared
with HDL-C level at zero time.
The interaction between time period and POS treatments
showed that, TG and VLDL-C were diminished by adminis-
tration of POS preparations for 4 and 8-weeks significantly
in comparison with each hyperlipidemic control (Table 2).
TG and VLDL-C of all treated groups were nearly equaled
after 4 and 8 weeks.
TL, TC and LDL-C were declined remarkably as a
response for administration POS preparations during 4 and
8 weeks, compared with each hyperlipidemic control
(PP 0.05). POS-ethanolic 70% showed the most amelioration
on TL, TC and LDL-C equivalent to respective value
52.68%, 56.35% and 86.62% respectively after 4-weeks in
the case of TL and after 8-weeks in the case of TC and
LDL-C, compared with hyperlipidemic control (Table 2 and
3).
HDL-C was boosted by feeding on HFD-POS-powder 10% or
force fed by POS-infusion or POS-alcoholic 70% during 4 and
8 weeks in comparison with hyperlipidemic control. The
influence of POS-powder 10% was more pronounced effect on
HDL-C (58.77%) followed by POS-ethanolic 70% (50.50%) after
8-weeks, with respect to hyperlipidemic control (Table 3).lucose of hyperlipidemic rates.
eeks 8-weeks Treat mean
.9efg ± 2.9 68.4e ± 2.8 65.8D
1.1b ± 1.9 117.3a ± 4.8 97.4A
.0i ± 4.7 73.9d ± 3.3 63.9D
.1d ± 1.3 77.0d ± 2.9 70.9C
.3c ± 1.7 67.8ef ± 2.6 74.4B
.5A 80.9A
e Interaction
4.6
ferent letter has significant at 0.05.
Table 2 Effect of Portulaca oleracea stems preparations on serum Total Lipids (TL), Triglycerides (TG) and Very low density lipoprotein (VLDL-C) of hyperlipidemic rates.
Parameters Total lipids (TL) Triglycerides (TG) Very low density lipoprotein (VLDL-C)
Time of
administration
Zero-day 4-weeks 8-weeks Treat.
mean
Zero-day 4-weeks 8-weeks Treat.
mean
Zero-day 4-weeks 8-weeks Treat.
mean
Untreated control 308.7hi ± 5.7 310.9h ± 15.1 328.3fg ± 6.6 315.9C 74.0f ± 3.3 78.1ef ± 8.0 84.2e ± 5.1 78.8C 14.8f ± 1.2 15.6ef ± 1.6 16.8e ± 1.0 15.8C
Hyperlipidemic
control
311.7gh ± 9.6 581.9b ± 14.9 608.5a ± 20.1 500.7A 75.0f ± 4.1 198.5b ± 26.9 224.5a ± 10.4 166.0A 15.0f ± 1.0 39.7b ± 5.4 44.9a ± 2.1 33.2A
HFD-POS-powder
10%
305.1hi ± 3.3 447.0c ± 16.9 348.9e ± 14.6 367.0B 75.8ef ± 4.5 99.1d ± 13.0 107.0cd ± 7.6 92.9B 15.2ef ± 0.1 19.8d ± 2.6 21.4cd ± 5.3 18.3B
HFD-POS-Infusion 313.3
gh ± 7.0 292.5ij ± 12.0 331.3f ± 8.8 312.4C 76.7ef ± 1.1 102.7cd ± 15.2 110.0c ± 12.2 96.5B 15.3ef ± 0.5 20.5cd ± 3.0 22.0c ± 2.4 19.3B
HFD-POS-ethanolic
70%
308.4hi ± 4.4 275.4j ± 8.7 368.9d ± 16.8 317.6C 75.8ef ± 4.5 104.4cd ± 6.9 104.0cd ± 8.2 94.8B 15.2ef ± 0.9 20.9cd ± 1.4 20.8cd ± 1.6 19.05B
Time mean 309.5C 381.5B 397.2A 75.5C 116.7mB 125.3A 15.1C 23.3B 25.2A
Treatments Time Interaction Treatments Time Interaction Treatments Time Interaction
LSD 9.89 7.66 17.13 4.88 3.78 8.46 0.98 0.76 1.69
Data in table were analyzed by two ways.
P 6 0.05, value with the same letter has no significant but value with different letter has significant at 0.05.
Table 3 Effect of Portulaca oleracea stems preparations on serum total cholesterol (TC), Low density lipoprotein (LDL-C) and High density lipoprotein (HDL-C) of hyperlipidemic
rates.
Parameters Total Cholesterol (TC) Low density lipoprotein (LDL-C) High density lipoprotein (HDL-C)
Time of
administration
Zero-day 4-weeks 8-weeks Treat
Mean
Zero-day 4-weeks 8-weeks Treat.
mean
Zero-day 4-weeks 8-weeks Treat.
mean
Untreated control 60.1f ± 1.9 70.4e ± 7.7 73.4e ± 1.1 68.1E 8.4ij ± 1.8 15.0fgh ± 10.8 16.0fg ± 11.6 13.1E 36.9bcd ± 3.1 40.2ab ± 8.6 40.6ab ± 5.8 39.2A
Hyperlipidemic
control
61.9f ± 2.4 155.9b ± 13.2 166.1a ± 6.7 128.0A 9.1ij ± 2.0 88.7c ± 17.6 95.4b ± 10.2 64.4A 37.7abcd ± 2.9 27.5e ± 4.4 25.9 ef ± 3.8 30.4C
HFD-POS-powder
10%
61.1f ± 3.8 132.5c ± 5.4 112.5d ± 2.8 102.1B 10.5hij ± 2.5 89.7c ± 7.7 50.0e ± 3.0 50.1B 35.5cd ± 1.2 23.1b ± 3.3 41.1a ± 1.5 33.2B
HFD-POS-Infusion 59.7
f ± 3.2 111.5d ± 9.9 76.3e ± 17.4 82.5D 6.8j ± 1.0 64.4d ± 5.8 19.4f ± 11.8 30.2D 37.6abcd ± 2.2 26.6ef ± 4.3 34.9d ± 6.9 33.0B
HFD-POS-ethanolic
70%
61.1f ± 3.8 154.0b ± 3.5 72.5e ± 4.1 95.9C 10.5hij ± 1.2 106.1a ± 4.1 12.8ghi ± 3.8 43.1C 35.5cd ± 1.2 27.0e ± 1.4 39.0abc ± 2.0 33.8B
Time mean 60.8C 125.0A 100.2B 9.1C 72.8A 38.7B 36.6A 28.9B 36.3A
LSD Treatments Time Interaction Treatments Time Interaction Treatments Time Interaction
3.43 2.66 5.93 3.11 2.41 5.38 2.27 1.76 3.94
Data in table were analyzed by two ways.
P 6 0.05, value with the same letter has no significant but value with different letter has significant at 0.05.
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Fig. 4 Effect of Portulaca oleracea stems preparations on daily body weight gain, daily food intake (g/day) of hyperlipidemic Wister
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Different preparations of Portulaca oleracea L. stem 117Risk ratio (LDL-C/HDL-C) was decreased significantly as
a response for treating by POS preparations for 8-weeks, with
respect to hyperlipidemic control as Fig. 4. POS-ethanolic 70%
recorded the highest decrease in risk ratio (90.08%) followed
by POS-infusion (84.86%) after 8-weeks, (PP 0.05). Treatments
showed significant influence in risk ratio and HFD-POS-infusion
group showed the lowest risk ratio values between other
groups treated with POS preparations with respect to hyper-
lipidemic control. Time period showed the same significant
influence on risk ratio. The risk ratio values were increased sig-
nificantly after 4-weeks and then returned to reduce after 8-
weeks again with respect to those of zero time.
Effect of POS on liver and renal functions
Liver and renal performances of rats of all groups at zero time
were nearly similar and in case normal. No significant differ-
ences were noticed between the values of total protein, albu-
min, AST and ALT of hyperlipidemic group or untreated
control. The same trend was observed with uric acid and urea
of all groups.
While administration of hyperlipidemic diet caused signifi-
cant disruption on liver and renal functions, significant reduc-
tion was recorded after 4 and 8 weeks in total protein (19.36%
and 33.33%), albumin (33.61% and 43.23%), uric acid
(40.81% and 83.61%) and urea (50.13% and 84.26% respec-
tively) of hyperlipidemic control rats with respect to each
untreated control. On the other hand, significant elevation
was showed after 4 and 8 weeks in AST (21.78% and
54.12%) and ALT (35.74% and 44.12%) of hyperlipidemic
control rats in comparison with each untreated control.
POS treatments had a significant effect on liver functions:
total protein, albumin, AST and ALT. POS enhanced total
protein and albumin production significantly, while AST and
ALT were declined significantly, compared with each hyper-
lipidemic control.
The time period showed a significant effect on liver func-
tions, with respect to zero time. Total protein and ALT were
raised after 4-weeks and then were reduced after 8-weeks, com-
pared with those of zero time. Another trend recorded with
albumin and AST which were decreased after 4-weeks and still
was decreasing after 8-weeks continuously.
Total protein and albumin were augmented significantly as
a response of POS treating and increasing time period
(Table 4). HFD-POS-powder 10% recorded the highest augment
of total protein after 4-weeks (27.65%) followed by HFD-POS-ethanolic 70% (18.80%) with respect to each hyperlipidemic
control (PP 0.05). The highest improvement on albumin was
recorded on HFD-POS-infusion group after 8-weeks (76.15%)
followed by HFD-POS-powder 10% group after 4-weeks
(30.70%) (Table 4). Globulin, which was calculated by the dif-
ference between total protein and albumin, did not change sig-
nificantly in all groups at all time.
Data presented in Table 5 showed that, administration of
POS preparations for 8-weeks waned AST and ALT levels of
rats significantly with respect to each hyperlipidemic control
(PP 0.05). The highest reduction of AST was recorded by
POS-infusion after 8-weeks, 47.11%, while the lowest value of
ALT was recorded in HFD-POS-ethanolic 70% group (48.61%)
followed by HFD-POS-infusion group (46.82%) after 8-weeks
with respect to hyperlipidemic control. POS-infusion put AST
of HFD-POS-infusion group lower than that of zero time. The
same observation was recorded on POS-ethanolic 70% on the case
of ALT.
As for the uric acid and urea levels, POS treatments had sig-
nificant effect on these rats, which administrated hyperlipi-
demic diet. POS-infusion recorded the highest influence on uric
acid and urea, compared with each hyperlipidemic control.
Time period had also significant effect on uric acid and urea.
Uric acid was affected after 8-weeks than 4-weeks, with respect
to that zero time. Urea was increased after 4-weeks and contin-
ued increase after 8-weeks, with respect to zero time.
Both uric acid and urea levels were reduced significantly as
a response to administration of POS preparations for 8-weeks
compared with hyperlipidemic control (Table 6). POS-ethanolic
70% recorded the highest decrease on uric acid (68.55%)
followed by POS-powder 10% (65.28%) with respect to hyperlipi-
demic control. All POS preparations decreased uric acid more
than those of untreated control. Both of HFD-POS-powder 10%
and HFD-POS-infusion recorded the highest decrease on urea
levels: 32.25% and 32.82% respectively after 4-weeks.
Effect of POS on body weight gain, food intake, feed efficiency
(EF) and relative weight of liver
Administration of hyperlipidemic diet dwindled daily body
weight gain, feed intake, feed efficiency (FE) and relative
weight of liver significantly by about 22.66%, 33.97%,
14.00% and 23.35% respectively on hyperlipidemic control
with respect to those of each untreated control (data presented
in Fig. 5). POS preparations decreased daily body weight
gain and feed intake significantly in comparison with
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118 S.A. El-Newaryhyperlipidemic control. HFD-POS-infusion group ingested the
lowest amount of food (24.24%) followed by HFD-
POS-ethanolic 70% group (17.80%), compared with hyperlipi-
demic control (PP 0.05; LD; 3.31). HFD-POS-ethanolic 70%
group growth was the lowest growth (23.57%) followed by
HFD-POS-infusion group (17.14%) with respect to hyperlipi-
demic control (PP 0.05; LSD; 0.27). The decrease in daily
body weight gain was parallel with the decrease in feed intake
of groups fed on POS-powder 10% and POS-ethanolic 70%, noticed
through decreasing feed efficiency, while feed intake on rats
treated by POS-infusion did not parallel with daily body weight
gain by increasing feed intake non-significantly, with respect to
hyperlipidemic control.
Relative weight of liver was decreased significantly by POS
preparations treating for 8 weeks in comparison with hyper-
lipidemic control. POS-powder 10% recorded the highest
decrease in relative weight of liver (25.25%) followed by
POS-infusion (15.53%). No significant difference was noticed
among relative weight of liver of HFD-POS-powder 10%,
HFD-POS-infusion and untreated control.
Histopathological studies
Untreated control rats revealed normal hepatic lobules with
normal central veins hepatic cords; sinusoids; and portal tracts
(normal hepatic artery; portal vein and bile duct) (Fig. 6). Rats
fed on hyperlipidemic diet showedmicro vesicular steatosis with
swollen and pale stained hepatocytes with granular cytoplasm
central to slightly eccentric nuclei with scattered aggregates of
chronic non-specific inflammatory cells i.e. lobular inflamma-
tion. Some cases showed lobules of signet ring hepatocytes with
clear cytoplasm and eccentric nuclei alternating with groups of
hepatocytes showing micro vesicular steatosis. The portal tract
was mildly distended by chronic inflammatory cells. Liver of
HFD-POS-powder 10% group showed swollen hepatocytes with
vesicular cytoplasm and central nuclei. Some cases showed
alternated dark areas of normal liver cords and pale areas of
fatty change including micro-vesicular steatosis and macro-
vesicular type (signet ring fatty change). Other cases showed
lobules of signet ring hepatocytes infiltrated by chronic
inflammatory cells or early granuloma formation. Liver of
HFD-POS-powder 10% was nearly similar to that of untreated
control than those of hyperlipidemic control. In liver section of
HFD-POS-infusion rats some cases showed interstitial infiltration
and portal aggregation of a small foci of chronic inflammatory
cells. Other cases appeared completely normal. Liver of HFD-
POS-ethanolic 70% sections revealed scattered foci of mild portal
inflammation, with normal hepatic lobules. POS-infusion and
POS-infusion liver sections were appeared with normal structure
mostly. Although feeding on hyperlipidemic diet, POS adminis-
tration at any form protected liver against fatty liver damage
and returned livers toward normalization.
Discussion
The initial phases of atherosclerotic fatty streak lesions occur
when macrophages take up oxidized LDL-C, which accumu-
late as lipid-laden foam cells in endothelial wall of cell. Antiox-
idants could prevent the development of atherosclerosis by
reducing LDL-C oxidation and increasing HDL-C.
In the present study POS preparations; POS-powder 10%,
POS-infusion and POS-ethanolic 70% were investigated as hypolipi-
Table 5 Effect of Portulaca oleracea stems preparations on serum AST and ALT of hyperlipidemic rates.
Parameters AST ALT
Time of
administration
Zero-day 4-weeks 8-weeks Treat.
Mean
Zero-day 4-weeks 8-weeks Treat.
mean
Untreated control 39.31d ± 0.39 37.84d ± 2.49 39.45d ± 2.86 38.87C 29.58d ± 0.33 29.24d ± 0.83 24.91e ± 1.12 27.91B
Hyperlipidemic
control
39.06d ± 0.57 46.08c ± 0.97 60.80a ± 2.33 48.65A 30.18d ± 0.29 39.69b ± 0.29 35.90c ± 1.14 35.26A
HFD-POS-powder
10%
38.66d ± 0.30 54.82b ± 2.01 52.24b ± 0.93 48.57A 29.78d ± 0.42 33.94c ± 1.56 44.76a ± 3.27 36.16A
HFD-POS-Infusion 38.80
d ± 0.53 45.22c ± 1.81 32.16e ± 1.71 38.73C 29.99d ± 0.22 29.07d ± 2.73 19.09f ± 1.87 26.05C
HFD-POS-ethanolic
70%
37.18d ± 1.91 52.94b ± 0.91 47.14c ± 0.89 45.87B 28.17d ± 2.79 28.17d ± 1.15 18.45f ± 0.42 24.93C
Time mean 38.60B 47.38A 46.43A 28.62B 32.02A 29.54B
Treatments Time Interaction Treatments Time Interaction
LSD 1.53 1.18 2.65 1.58 1.23 2.74
Data in table were analyzed by two ways.
P 6 0.05, value with the same letter has no significant but value with different letter has significant at 0.05.
Table 6 Effect of Portulaca oleracea stems preparations on serum uric acid and urea of hyperlipidemic rates.
Parameters Uric acid Urea
Time of administration Zero-day 4-weeks 8-weeks Treat mean Zero-day 4-weeks 8-weeks Treat mean
Untreated control 5.6cd ± 0.2 5.0def ± 0.3 4.3f ± 0.2 4.9B 24.5ef ± 0.7 23.9f ± 0.2 29.0de ± 4.4 25.8C
Hyperlipidemic control 5.3cde ± 0.31 7.0b ± 0.6 8.0a ± 0.9 6.7A 25.2ef ± 0.5 35.8c ± 0.9 53.5a ± 6.1 38.2A
HFD-POS-powder 10% 5.1
cde ± 0.1 4.6ef ± 0.36 2.8gh ± 0.8 4.1C 24.2f ± 2.6 24.3f ± 2.4 30.0d ± 2.7 26.1C
HFD-POS-Infusion 5.2
cde ± 0.3 5.7c ± 0.1 3.4g ± 0.4 4.7B 23.8f ± 1.1 24.1f ± 3.5 40.5b ± 4.2 29.5B
HFD-POS-ethanolic 70% 5.3
cde ± 0.4 5.0def ± 0.5 2.5h ± 0.5 4.2C 24.6ef ± 0.8 40.4bc ± 1.4 42.5b ± 1.7 35.8A
Time mean 5.3A 5.4A 4.2B 24.4C 29.7B 39.1A
Treatments Time Interaction Treatments Time Interaction
LSD 0.41 0.32 0.71 2.66 2.06 4.60
Data in table were analyzed by two ways.
P 6 0.05, value with the same letter has no significant but value with different letter has significant at 0.05.
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Fig. 5 Effect of Portulaca oleracea stems preparations on risk ratio of hyperlipidemic Wister Albino rats.
Different preparations of Portulaca oleracea L. stem 119demic agents for 8-weeks compared with untreated control.
Dietary hyperlipidemic rats were used in this study as a hyper-
lipidemic dietary models. These models were characterized by
elevated TL, TG, VLDL-C, TC, LDL-C levels and decreased
HDL-C level. This hyperlipidemic rats had highly risk ratio
reached to about ten times of those of untreated control, as
well as elevation on glucose and disruption on liver and renal
functions. Liver of these rats showed fatty changes reached to
fatty liver damage including signet ring hepatocytes and
chronic inflammatory cells.
POS treatments showed significant hypoglycemic effect and
the highest hypoglycemic effect recorded by POS-powder 10%.Obtained results are on the line of those of Fujita and
Yamagami (2008) on water-soluble extract of black tea,
Badal et al. (2011) on Menth piperita leaves infusion, El-
Newary et al. (2011) on P. oleracea seeds, Masani et al.
(2012) on vitis vinifera fruits juice. Thus, the significant antihy-
perglycemia activity of POS preparations may be attributed to
the presence of polyphenols reported as a major role in reduc-
ing oxidative stress-associated diabetes and hyperlipidemia
which helps the regulation of plasma glucose levels and hepatic
glucose metabolism (Du Thie and Crozier, 2000). Many
researchers confirmed that polyphenols, catechins and water-
soluble polysaccharide fractions of tea reduced serum glucose
Liver of untreated control showing normal hepatic lobules with normal central veins hepatic cords; sinusoids; and portal tracts 
(normal hepatic artery; portal vein &bile duct), H&Ex300 (A), x1200(B)
A B
Liver of hyperlipidemic control rats, showing micro vesicular steatosis and lobular aggregation of chronic inflammatory cells (A) and 
macro-vesicular steatosis together with portal aggregation of chronic inflammatory cells (B).H&Ex1200
Liver of HF-POS- powder 10% showing alternating dark areas of normal liver cords & pale areas of fatty change including micro-vesicular 
steatosis and macro-vesicular type (signet ring fatty change) (A&B). Other cases show lobules of signet ring hepatocytes infiltrated by 
chronic inflammatory cells or early granuloma formation (C&D).H&EX300(A),x1200(B,C,D)
Liver of HF-POS- infusion showing normal structures apart of   interstitial infiltration and portal aggregation of small foci of chronic 
inflammatory cells.H&Ex300
Liver HF-POS- ethanolic 70% showing scattered foci of mild portal inflammation, with normal hepatic lobules.H&Ex300 (A), x1200(B).
A B
A B
C  D
A B
A B
Fig. 6 Histopathological of liver sections of rats treated with different preparation of Portulaca oleracea stems compared with
hyperlipidemic and untreated control.
120 S.A. El-Newaryin rats feed high fat diet by increasing muscle glucose trans-
porter (Bose et al., 2008; Suzuki et al., 2012). Liao et al.
(2001) and Chemler et al. (2007) reported that polyphenols
were able to inhibit digestive enzymes such as salivary amylase,
intestinal sucrase and a-glucosidase, which reduced digestibil-
ity action and promotes pancreatic b-cells regeneration.
POS preparations improved lipid profile toward normaliza-
tion. This effect of POS preparations was appeared in a
remarkably reduction in TL, TG and VLDL-C, TC and
LDL-C, and increased HDL-C significantly, compared withhyperlipidemic control. Therefore risk ratio was reduced sig-
nificantly. Among all POS preparations, POS-infusion showed
the most pronounced effect on lipid metabolism of hyperlipi-
demic rats. These results agreed with those of Khanna et al.
(2002) on Phyllanthus niruri, Lee et al. (2005) on Solanum
nigrum Linne, Pourghassem-Gargari et al. (2009) on Nigella
sativa L. dietary fibers, Lee et al. (2010) on buckwheat leaf
and flower, Lim et al. (2013) on Artemisia capillaris, Chiang
et al. (2013) on Polygonatum alte-lobatum Hayata extract,
Thirumalai et al. (2014) on Piper betel, Ragab et al. (2014)
Different preparations of Portulaca oleracea L. stem 121on quercetin, o-coumaric and berberine, Jegadeesh et al. (2014)
on Pleurotus djamor var. roseus mushroom and Sulieman and
El-newary (2014) on C. dichotoma pulp.
On the other hand a significant decrease in TG level may be
by enhancing the activity of lipase enzyme or by increasing
excretion of TG via feces (Sukla et al., 2004). Polyphenol-
rich decreased intestinal absorption of TG by inhibition of
pancreatic lipase (Ikeda et al., 2005) and increased lipoprotein
lipase (PLP) activity (Zern and Fernandez, 2005). The action
of the LPL increases by phenolic compounds of the grape seed
(Del Bas et al., 2005). Cholesterol-lowering activity of pheno-
lics can result from the rapid catabolism of LDL-C through its
hepatic receptors for final elimination in the form of bile acids
as demonstrated by Khanna et al. (2002). POS preparations
contained polyphenolic compounds ranged between 2.35%
and 6.69%.
HDL transported cholesterol by peripheral tissues to the
liver for catabolism causing significant reduction in TC, TG
and VLDL. POS preparations recorded significant increase
on HDL-C of treated hyperlipidemic rats.
Dietary fiber’s (DF), either soluble fibers (SDF) or insoluble
fibers (IDF) pass through the stomach and small intestine and
undigested, but it fermented in the large intestine by colonic bac-
teria causes cholesterol decreasing. It produces short chain fatty
acids such as acetic, propionic, and butyric acids. In particular,
propionate inhibited cholesterol and fatty acids synthesis in the
liver (Tucker and Thomas, 2009). High concentrations of short-
chain fatty acid caused concentration in acid colonic pH, which
could lower the solubility and reabsorption of bile acids. In addi-
tion to this fermentation produces glucagon-like peptide (GLP-
1) and peptide YY (PYY), which are gut hormones related to
satiety (Keenan et al., 2006). DF, especially viscous soluble
polysaccharides (VSF) was trapped bile salts in the viscous
matrix formed by SDF polysaccharides in the gut. To compen-
sate for the increased fecal excretion of bile salts, cholesterol is
derived by the synthesis of bile acids. SDF form gel or viscosity
builders in the intestine that reduce translational diffusion and
absorption of all food ingredients including cholesterol and
reabsorption of bile acids in the lumen (Sable et al., 1990; Carr
et al., 1996). Flaxseeds and flaxseed lignan extracts contain a
water-soluble fiber known as mucilage, which hydrates and
can swell in the intestine (Easterby and Jones, 1950). As such,
the consumption of large amounts of flaxseeds or flaxseed lignan
extracts may be associated with intestinal discomfort and
intestinal obstruction (Struthers, 1986), as well as soluble fibers,
hinder digestion and absorption of dietary fats. Therefore,
cholesterol delivery to the liver by chylomicron remnants was
decreased, with a concomitant upregulation of LDL receptor
and decreased lipoprotein secretion to maintain cholesterol
homeostasis in the liver (Jalili et al., 2001; Anderson et al.,
2000). In our unpublished data recorded dietary fibers of C.
dichotoma pulp increased fecal excretion and fecal fat excretion
of rats fed on hyperlipidemic diet supplemented with 10% or
20% of C. dichotoma pulp powder. POS-powder and
POS-infusion had a high amount of mucilage as a soluble fiber:
11.08% and 21.42% respectively.
Insoluble dietary fibers (IDF) dilutes gastrointestinal con-
tents may hinder digestion and absorption of dietary fats.
The mode of action behind these findings may be due to the
fact that IDF causes an increased rate of passage through
the GI tract (Anderson, 1985). POS-powder 10% contains high
amount of crude fibers 24.11 ± 1.05%.Flavonoids have been shown to possess a variety of bio-
chemical and pharmacological activities, including hypolipi-
demic effects, cardio-protective and antioxidant properties
(Ribeiro et al., 2001). Flavonoids decreased TC, LDL-C and
VLDL-C but increased HDL-C, and may be due to increase
in lipolysis more than lypogenisis Koshy et al. (2001). POS
preparations contain flavonoids about 0.52 and 1.16 g
quercetin/100 g.
For Alkaloids, Francis et al. (2002) and Alexander et al.
(2008) reported that alkaloids causes dryness on the mucosa
in the upper gastrointestinal tract. And it prevents the binding
of acetylcholine by antagonizing the muscarinic acetylcholine
receptors. Since acetylcholine is the transmitter responsible
for the peristaltic and segmentation movements in the small
intestine, blockage of these receptors causes a delay, slowing
down of activities or blocking of the smooth muscle contrac-
tion (Alexander et al., 2008). POS preparations contain high
amount of crude alkaloids ranged between 1.65% and 11.68%.
POS preparations contain saponins ranged from 0.29% to
2.15% and tannins about 0.18–0.27%. Saponins prevent
cholesterol absorption through interfering with its enterohep-
atic circulation and increasing cholesterol fecal excretion
(Johnes et al., 1995). Also tannins have been reported to
reduce cholesterol levels by increasing fecal bile acids excretion
(Parab and Mengi, 2002).
Injury to liver tissues due to hyperlipidemia alters their trans-
port function andmembrane permeability, leading to leakage of
enzymes from the cells. Therefore, the marked release of AST
andALT into the circulation indicates severe damage to hepatic
tissue membranes (Ahn et al., 2007). Administration of POS
returned liver and renal functions toward normalization with
respect to hyperlipidemic control. This protective action of
POS may be due to enhancement of hepatic steatosis and fat
accumulation in liver. In this report, POS preparations
improved histology of livers of rats treated rats and restored
them close to untreated control liver. These results in the line
of those of Ghule et al. (2009) on Lagenaria siceraria Stand.
fruit, Nib et al. (2012) on Orange Juice, Kodali and Seru
(2013) on Boswellia ovalifoliolata Bal, Bakr and Header (2014)
on Aqueous Extract of Green Tea (Camellia Sinensis L.).
The weight loss in this study due to POS preparations
administration was associated with decreasing food intake,
hyperglycemia, may promote insulin sensitivity, thus lowering
insulin resistance in obese rats, possibly by regulating the cell
energy metabolism or reducing free fatty acids (Rajasekar
and Anuradha, 2007), and decreasing of fat absorption and
lipogenic enzymes and increasing of fat excretion uncoupling
proteins, thermogenesis (Rains et al., 2011). In the present
study reduced body weight gain may be due to improvement
in gastrointestinal motility and influence colonic motility
thereby reducing fluid absorption and facilitating weight loss
(Amin and Nagy, 2009). These obtained finding were in accor-
dance with those of Lee et al. (2011) on Laminaria japonica,
Seo et al. (2012) on aged garlic extract, Bakr and Header
(2014) on aqueous extract of green tea (C. Sinensis L.).Conclusion
The current study was carried out to estimate the weight
lowering, hypolipidemic and hepatoprotective effect of POS
preparations; POS-powder 10%, POS-infusion and POS-ethanolic 70%
122 S.A. El-Newaryon rats fed on hyperlipidemic diet. The obtained results
showed that; POS preparations decreased both of daily body
weight gain and daily food intake of hyperlipidemic rats.
Disrupted lipid profile of rats was ameliorated significantly
by administration POS preparations for 8 weeks, compared
to hyperlipidemic rats. Liver status was enhanced remarkably
either on liver functions or on liver histology. This hypo-
lipidemic effect of POS preparations; POS-powder 10%,
POS-infusion and POS-ethanolic 70% might be due to its contents
from polyphenolics, flavonoids, alkaloids, crude fiber and
mucilage, which have been documented as a hypolipidemic
agents. These findings are indicating that the POS prepara-
tions; POS-powder 10%, POS-infusion and POS-ethanolic 70% have
a good weight lowering, hypolipidemic and hepatoprotective
properties with margin of safety. POS did not receive the
enough attention from studying and investigation, although
production of stems was more economic. So it could be recom-
mended with more studies on POS.
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